pruritus
Showing NaN - NaN of 12
Dermatitis, Atopic, Pruritus Trial in United States (ASN008, ASN008 Matching Vehicle)
Recruiting
- Dermatitis, Atopic
- Pruritus
- ASN008
- ASN008 Matching Vehicle
-
Scottsdale, Arizona
- +17 more
May 24, 2023
Pruritus, Notalgia Paresthetica Trial in Canada, United States (difelikefalin 2.0 mg, Placebo)
Completed
- Pruritus
- Notalgia Paresthetica
- difelikefalin 2.0 mg
- Placebo
-
Fort Smith, Arkansas
- +35 more
Aug 1, 2022
Pruritus Trial in United States (5 mg Serlopitant Tablets, Matching Placebo Tablets)
Completed
- Pruritus
- 5 mg Serlopitant Tablets
- Matching Placebo Tablets
-
Hot Springs, Arkansas
- +40 more
May 18, 2021
Pruritus, Prurigo Nodularis Trial in United States (5mg Serlopitant Tablets, Placebo Tablets)
Completed
- Pruritus
- Prurigo Nodularis
- 5mg Serlopitant Tablets
- Placebo Tablets
-
Birmingham, Alabama
- +48 more
May 18, 2021
Pruritus, Psoriasis Trial in United States (5 mg Serlopitant Tablets, Matching Placebo Tablets)
Completed
- Pruritus
- Psoriasis
- 5 mg Serlopitant Tablets
- Matching Placebo Tablets
-
Bryant, Arkansas
- +38 more
May 18, 2021
Pruritus, Atopic Dermatitis Trial in United States (Serlopitant High Dose, Placebo Oral Tablet, Serlopitant Low Dose)
Completed
- Pruritus
- Atopic Dermatitis
- Serlopitant High Dose
- +2 more
-
Anniston, Alabama
- +51 more
May 18, 2021
Chronic Kidney Diseases, Pruritus Trial in United States (CR845 0.25 mg Oral Tablet, CR845 0.5 mg Oral Tablet, CR845 1 mg Oral
Completed
- Chronic Kidney Diseases
- Pruritus
- CR845 0.25 mg Oral Tablet
- +3 more
-
Birmingham, Alabama
- +59 more
Oct 22, 2020
Dermatitis, Atopic, Pruritus, Dermatitis Eczema Trial in Canada, United States (ASN008 TG, Placebo TG)
Completed
- Dermatitis, Atopic
- +2 more
- ASN008 TG
- Placebo TG
-
Cortland, New York
- +4 more
May 27, 2020
Pruritus, Uremic Pruritus Trial in United States (Part A: Placebo, Part A: CR845 0.5 mcg/kg, Part A: CR845 1.0 mcg/kg)
Completed
- Pruritus
- Uremic Pruritus
- Part A: Placebo
- +5 more
-
Pine Bluff, Arkansas
- +19 more
Aug 8, 2016